Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence (Frontiers in Immunology, (2023), 14, (1265044), 10.3389/fimmu.2023.1265044)

Abstract

In the published article, there were two errors: The “Material and methods” section preceded the “Introduction” section, and there was an inaccuracy in the wording of a sentence in the “Reagents” sub-section of “Material and methods”. The “Introduction” now precedes the “Material and methods”, and a correction has been made to a sentence in “Materials and methods”, sub-section “Reagents”. This sentence previously stated: “Peptides were synthesized by GenScript (Piscataway, NJ, USA) at a purity ≥85%, and used at a final concentration of 1.5mg/mL each.” The corrected sentence appears below: “Peptides were synthesized by GenScript (Piscataway, NJ, USA) at a purity ≥85% and stored at a final concentration of 1.5mg/mL.” The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.